MR imaging for the longevity of mesenchymal stem cells labeled with poly-L-lysine-Resovist complexes

Contrast Media and Molecular Imaging

Volumn 5, Issue 2, 2010, Pages 53-58

  Liu, Gang ^a   Yang, Hua ^a,b   Zhang, Xiao Ming ^a   Shao, Yang ^a   Jiang, Hong ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Magnetic labeled cells; Magnetic resonance; Mesenchymal stem cells; Poly L lysine; Resovist

Indexed keywords

FERUCARBOTRAN; POLYLYSINE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL LABELING; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

ANIMALS; CELL SURVIVAL; CONTRAST MEDIA; FERROSOFERRIC OXIDE; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELLS; POLYLYSINE; RESEARCH DESIGN;

EID: 77951564318     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.362     Document Type: Article

References (33)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147. (Pubitemid 29282067)
2. Schroeder T. Imaging stem-cell-driven regeneration in mammals. Nature 2008; 453: 345-351.
3. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imag 1997; 7: 258-263. (Pubitemid 28365670)
4. Sun S. Recent advances in chemical synthesis, self-assembly, and applications of FePt nanoparticles. Adv Mater 2006; 18: 393-403. (Pubitemid 43305221)
5. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838-846. (Pubitemid 37467591)
6. Kalish H, Arbab AS, Miller BR, Lewis BK, Zywicke HA, Bulte JW, Bryant LH Jr, Frank JA. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 2003; 50: 275-282. (Pubitemid 36950846)
7. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004; 104: 1217-1223 (Pubitemid 39038047)
8. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004; 17: 513-517. (Pubitemid 39549429)
9. Suzuki Y, Zhang S, Kundu P, Yeung AC, Robbins RC, Yang PC. In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides. Magn Reson Med 2007; 57: 1173-1179.
10. Babic M, Horák D, Trchová M, Jendelová P, Glogarová K, Lesný P, Herynek V, Hájek M, Syková E. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 2008; 19: 740-750 (Pubitemid 351431406)
11. Kim HS, Choi Y, Song IC, Moon WK. Magnetic resonance imaging and biological properties of pancreatic islets labeled with iron oxide nanoparticles. NMR Biomed 2009; 22: 852-856.
12. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319-2331. (Pubitemid 33041104)
13. Boutry S, Brunin S, Mahieu I, Laurent S, Vander Elst L, Muller RN. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. Contrast Media Mol Imaging 2008; 3: 223-232.
14. Mailänder V, Lorenz MR, Holzapfel V, Musyanovych A, Fuchs K, Wiesneth M, Walther P, Landfester K, Schrezenmeier H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 2008; 10: 138-146.
15. He G, Zhang H,Wei H,Wang Y, Zhang X, Tang Y,Wei Y, Hu S. In vivo imaging of bone marrow mesenchymal stem cells transplanted into myocardium using magnetic resonance imaging: a novel method to trace the transplanted cells. Int J Cardiol 2007; 114: 4-10.
16. Qu ZH, Zhang XL, Tang TT, Dai KR. Promotion of osteogenesis through beta-catenin signaling by desferrioxamine. Biochem Biophys Res Commun 2008; 370: 332-337.
17. Heymer A, Haddad D, Weber M, Gbureck U, Jakob PM, Eulert J, Nöth U. Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials 2008; 29: 1473-1483.
18. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005; 54: 769-774. (Pubitemid 41457046)
19. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219: 316-333.
20. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17: 484-499. (Pubitemid 39549426)
21. Smirnov P, Lavergne E, Gazeau F, Lewin M, Boissonnas A, Doan BT, Gillet B, Combadière C, Combadière B, Clément O. In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy. Magn Reson Med 2006; 56: 498-508.
22. Billotey C, Aspord C, Beuf O, Piaggio E, Gazeau F, Janier MF, Thivolet C. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging. Radiology 2005; 236: 579-587. (Pubitemid 41023443)
23. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004; 14: 1851-1858. (Pubitemid 39386634)
24. Chung TH, Wu SH, YaoM, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007; 28: 2959-2966. (Pubitemid 46560868)
25. Thorek DL, Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 2008; 29: 3583-3590.
26. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18: 410-414. (Pubitemid 30217528)
27. Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003; 49: 1006-1013. (Pubitemid 36627278)
28. Zhang C, Jugold M, Woenne EC, Lammers T, Morgenstern B, Mueller MM, Zentgraf H, Bock M, Eisenhut M, Semmler W, Kiessling F. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 2007; 67: 1555-1562.
29. Jiao Y, Peng ZH, Zhang JY, Qin J, Zhong CP. Liposome-mediated transfer can improve the efficacy of islet labeling with super-paramagnetic iron oxide. Transplant Proc 2008; 40: 3615-3618.
30. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005; 18: 553-559.
31. Lu CW, Hung Y, Hsiao JK, Yao M, Chung TH, Lin YS,Wu SH, Hsu SC, Liu HM, Mou CY, Yang CS, Huang DM, Chen YC. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 2007; 7: 149-154.
32. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002; 48: 52-61.
33. Yablonskiy DA, Haacke EM. Theory of NMR signal behavior in magnetically homogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32: 749-763.